Pathway proteomics: Global and focused approaches

American Journal of PharmacoGenomics

Volumn 5, Issue 2, 2005, Pages 113-122

  Marko Varga, György ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

CELL COMMUNICATION; ELECTROSPRAY; ENZYME PHOSPHORYLATION; INFLAMMATORY DISEASE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SEPARATION TECHNIQUE; SIGNAL TRANSDUCTION; STOICHIOMETRY; T LYMPHOCYTE;

ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TECHNOLOGY, PHARMACEUTICAL;

EID: 17844393883     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200505020-00004     Document Type: Review

References (72)

1. Petricoin E, Hackett J, Lesko L, et al. Medical applications of microarray technologies: a regulatory science perspective. Nat Genet 2002; 32: 474-9
2. Hanash SH, Bobek MP, Rickman DS, et al. Integrating cancer genomics and proteomics in the post-genome era. Proteomics 2002; 2: 69-75
3. Ljung B, Bamberg K, Dahllof B, et al. AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats. J Lipid Res 2002; 43: 1855-63
4. Rees J. Complex disease and the new clinical sciences. Science 2002; 296: 698-700
5. Wilkins MR, Williams KL, Appel RD, et al., editors. Proteome research: new frontiers in functional genomics. Heidelberg: Sprinter-Verlag, 1997
6. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003; 2: 198-207
7. Mann M, Hendrickson RC, Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem 2001; 70: 437-73
8. Wu S-L, Choudhary G, Ramström M, et al. Evaluation of shotgun sequencing for proteomic analysis of human plasma using HPLC coupled with either ion trap or Fourier transform mass spectrometry. J Proteome Res 2003; 2: 383-93
9. The Nobel Prize in chemistry 2002. The Nobel Foundation [online]. Available from URL: http://www.nobel.se/chemistry/laureates/2002/index.html [Accessed 2004 Jun 14]
10. Fenn J, Mann M, Meng CK, et al. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989; 246: 64-71
11. Tanaka K, Ido Y, Akita S, et al. Detection of high mass molecules by laser desorption time-of-flight mass spectrometry. Proceeding of the Second Japan-China Joint Symposium on Mass Spectrometry; 1987 Sep 15-18; Osaka; 185-8
12. Lander E, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921
13. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001; 291: 1304-51
14. Gygi SP, Rist B, Gerber SA, et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999; 17: 994-9
15. McDonald WH, Yates JR. Shotgun proteomics: integrating technologies to answer biological questions. Curr Opin Mol Ther 2003; 5: 302-9
16. Malmström J, Larsen K, Malmström L, et al. Nanocapillary liquid chromatography interfaced to tandem matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry: mapping the nuclear proteome of human fibroblasts. Electrophoresis 2003; 24: 3806-14
17. Fey SJ, Larsen PM. 2D or not 2D: two-dimensional gel electrophoresis. Curr Opin Chem Biol 2001; 5: 26-33
18. Anderson L, Anderson J. Back to the future: the human protein index and the agenda for post-proteomic biology. Proteomics 2000; 1: 1-13
19. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997; 18: 533-7
20. Human Proteome Organisation [online]. Available from URL: http://www.HUPO.org [Accessed 2004 Jun 14]
21. Camon E, Magrane M, Barrell D, et al. The Gene Ontology Annotation (GOA) project: implementation of GO in SWISS-PROT, TrEMBL, and InterPro. Genome Res 2003; 13: 662-72
22. Parker DS, Gorlick MM, Lee CJ. Evolving from bioinformatics in-the-small to bioinformatics in-the-large. OMICS 2003; 7: 37-48
23. Bouwmeester T, Bauch A, Ruffner H, et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 2004; 2: 97-105
24. Giaever G, Chu AM, Ni L, et al. Global analysis of protein expression in yeast. Nature 2003; 425: 737-41
25. Giot L, Bader JS, Brouwer C, et al. A protein interaction map of Drosophila melanogaster. Science 2003; 302: 1727-36
26. Persidis A. Signal transduction as a drug discovery platform. Nat Biotechnol 1998; 16: 1082-3
27. Pawson T, Nash P. Assembly of cell regulatory systems through protein interaction domains. Nature 2003; 300: 445-52
28. Ideker T, Thorsson V, Ranish JA, et al. Integrated genomic and proteornic analyses of a systematically perturbed metabolic network. Science 2001: 292: 929-34
29. Peng J, Andersen K, IUBMB Life. The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease. 2003; 55: 267-71
30. Desmouliere A, Geinoz A, Gabbiani F, et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. Cell Biol 1993; 122: 103-11
31. Steed PM, Tansey MG, Zalevsky J, et al. Inactivation of TNF signaling by rationally designed dominant-negative TNF variants. Science 2003; 301: 1895-8
32. Becker J. Signal transduction inhibitors: a work in progress. Nat Biotechnol 2004; 22: 15-8
33. Gulliford T, Jhuang G, Ouyang X, et al. Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2. Oncogene 1997; 15: 2219-23
34. Wilkinson JC, Staros JF. Effect of ErbB2 coexpression on the kinetic interactions of epidermal growth factor with its receptor in intact cells. Biochemistry 2002; 41: 8-14
35. Moriki T, Maruyama H, Maruyama IM. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J Mol Biol 2001; 311: 1011-26
36. Yarden Y, Siwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2: 127-37
37. Jorrisen RN, Walker F, Pouliot N, et al. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003; 284: 31-53
38. Blagoev B, Kratchmarova I, Ong SE, et al. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 2003; 21: 315-8
39. Verheijen MH, Wolthuis RM, Defize LH, et al. Interdependent action of RalGEF and Erk in Ras-induced primitive endoderm differentiation of F9 embryonal carcinoma cells. Oncogene 1999; 18: 4435-9
40. Van Weering DH. Protein kinase B activation and lamellipodium formation are independent phosphoinositide 3-kinase-mediated events differentially regulated by endogenous Ras. Mol Cell Biol 1998; 18: 1802-11
41. Brown D, Superti-Furga G. Rediscovering the sweet spot in drug discovery. Drug Discov Today 2003; 8 (23): 1067-77
42. Cordwell SJ, Basseal DJ, Humphery-Smith I. Proteome analysis of Spiroplasma melliferum (A56) and protein characterisation across species boundaries. Electrophoresis 1997; 18: 1335-46
43. Uetz P, Giot L, Cagney G, et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000; 403: 623-7
44. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000; 1: 169-78
45. Malmström J, Larsen K, Hansson L, et al. Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study. Proteomics 2002; 2: 394-404
46. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67: 753-91
47. Kretzschmar M, Liu F, Hata A, et al. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 1997; 11: 984-95
48. Heldin CH, Eriksson U, Ostman A. New members of the platelet-derived growth factor family of mitogens: new members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys 2002; 398: 284-90
49. Ten Dijke P, Goumans MJ, Itoh F, et al. Regulation of cell proliferation by Smad proteins. J Cell Physiol 2002; 191: 1-16
50. Liu F, Hata A, Baker JC, et al. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 1996; 381: 620-3
51. Bratt C, Lindberg C, Lindberg C, et al. Restricted access chromatographic sample preparation of low mass proteins expressed in human fibroblast cells for proteomics analysis. J Chromatogr A 2001; 909: 279-88
52. Malmström J, Bratt C, Lindberg H, et al. Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus. Mol Cell Proteomics 2004 May; 3 (5): 466-77
53. Westergren-Thorson G, Malmström J, Marko-Varga G. A proteomic approach to mimic fibrosis disease evolvement by an in vitro cell line. Electrophoresis 2001; 22: 1776-84
54. Westergren-Thorson G, Malmström J, Marko-Varga G. Proteomics: the protein expression technology to study connective tissue biology. J Pharm Biomed Anal 2001; 24: 815-24
55. Malmström L, Malmström J, Marko-Varga G, et al. Proteomic 2DE database for spot selection, automated annotation, and data analysis. J Proteome Res 2002; 2: 135-8
56. Malmström J, Larsen K, Malmström L, et al. Proteome annotations and identifications of the human pulmonary fibroblast. J Proteome Res 2004 May-Jun 30; 3 (3): 525-37
57. Imamura T, Kanai F, Kawakami T, et al. Proteomic analysis of the TGF-beta signaling pathway in pancreatic carcinoma cells using stable RNA interference to silence Smad4 expression. Biochem Biophys Res Commun 2004; 318: 289-96
58. Anderson NL, Anderson NG. The Human Plasma Proteome: History, Character, and Diagnostic Prospects. Mol Cell Proteomics 2003; 2: 845-67
59. Endo Y, Ishikawa O, Negishi I. Zeta-chain-associated protein-70 molecule is essential for the proliferation and the final maturation of dendritic epidermal T cells. Exp Dermatol 2005; 14 (3): 188-93
60. Watts JD, Affolter M, Krebs DL, et al. Identification by electrospray ionization mass spectrometry of the sites of tyrosine phosphorylation induced in activated Jurkat T cells on the protein tyrosine kinase ZAP-70. J Biol Chem 1994; 269: 29520-9
61. Guillaume S, Tuosto L, Tanchot C, et al. Proximal changes in signal transduction that modify CD8+ T cell responsiveness in vivo. Eur J Immunol 2003; 33: 2551-6
62. Chu DH, Morita CT, Weiss A. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol Rev 1998; 165: 167-80
63. Miliotis T, Ericsson P-E, Marko-Varga G, et al. Analysis of regulatory phosphorylation sites in ZAP-70 by capillary high-performance liquid chromatography coupled to electrospray ionization or matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J Chromatogr B 2001; 752: 323-34
64. Miliotis T. Interfacing HPLC with MALDI and ESI-MS for automated high sensitivity analysis of proteins and peptides [doctoral thesis]. Lund: Lund University, 2002
65. Miliotis T, Ericsson P-E, Marko-Varga G, et al. Capillary LC-MS in the analysis of regulatory phosphorylation sites in human ZAP70. Poster at the 15th European Symposium on Mass Spectrometry; 2001 Sep 15-18; Barcelona
66. Laurell T, Nilsson J, Marko-Varga G. Silicon microstructures for high-speed and high-sensitivity protein identifications. J Chromatogr B 2001; 752: 217-32
67. Laurell T, Nilsson J, Marko-Varga G. Proteomics-protein profiling technology: the trend towards a microfabricated toolbox concept. TRAC-Trends Anal Chem 2001; 20: 225-31
68. Anderson NL, Anderson NG. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 2004 Apr; 3 (4): 311-26
69. Petricoin EF, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 35: 572-7
70. Tirumalai R, Chan KC, Prieto DA, et al. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2003; 2: 1096-103
71. Liu J, Ferrari M. Mechanical spectral signatures of malignant disease?. A small-sample, comparative study of continuum vs. nano-biomechanical data analyses. Dis Markers 2002; 18: 175-83
72. Petricoin E, Wulfkuhle J, Espina V, et al. Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. J Proteome Res 2004; 3: 209-17